KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Operating Income (2016 - 2025)

Chemed (CHE) has 17 years of Operating Income data on record, last reported at -$162.9 million in Q4 2025.

  • For Q4 2025, Operating Income rose 3.47% year-over-year to -$162.9 million; the TTM value through Dec 2025 reached $74.7 million, down 10.94%, while the annual FY2025 figure was $74.7 million, 10.94% down from the prior year.
  • Operating Income reached -$162.9 million in Q4 2025 per CHE's latest filing, down from $74.8 million in the prior quarter.
  • Across five years, Operating Income topped out at $111.4 million in Q4 2023 and bottomed at -$192.9 million in Q4 2022.
  • Average Operating Income over 5 years is $45.6 million, with a median of $80.6 million recorded in 2021.
  • Peak YoY movement for Operating Income: soared 160.04% in 2021, then tumbled 296.82% in 2022.
  • A 5-year view of Operating Income shows it stood at $98.0 million in 2021, then crashed by 296.82% to -$192.9 million in 2022, then skyrocketed by 157.74% to $111.4 million in 2023, then tumbled by 251.47% to -$168.7 million in 2024, then rose by 3.47% to -$162.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were -$162.9 million in Q4 2025, $74.8 million in Q3 2025, and $68.1 million in Q2 2025.